Finally, the CXCR2 chemical inhibitor SB225002 and CXCR2 shRNA confirmed that the CXCL1/CXCR2 axis is required for VCAM-1 expression and mobility of osteosarcoma cells (Figure 4H–K). Here, CXCL1 is linked to osteosarcoma.